VALEANT PHARMACEUTICALS NORTH AMERICA

Patent Owner

Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 8239
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 489
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2122
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 187
 
 
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1123
 
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1139

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,575,331 Synthesis and use of 2′-substituted-N6-modified nucleosidesSep 07, 10Nov 05, 13[C07H]
7,799,832 Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating painsDec 05, 03Sep 21, 10[A61K]
7,799,908 -modified nucleosidesJan 15, 04Sep 21, 10[C07H]
7,638,496 Nucleoside analogs with carboxamidine modified monocyclic baseAug 22, 02Dec 29, 09[A01N, A61K]
7,329,241 Drug delivery system for administering an adjustable preset doseFeb 14, 03Feb 12, 08[A61M]
7,217,815 2-beta -modified-6-substituted adenosine analogs and their use as antiviral agentsOct 23, 02May 15, 07[C07H]
7,056,895 Tirazole nucleoside analogs and methods for using sameMar 11, 02Jun 06, 06[A61K]
6,538,151 Modifications of 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminobenzene, and processes for their preparationOct 29, 98Mar 25, 03[C07C]
6,495,677 Nucleoside compoundsJun 16, 00Dec 17, 02[C07H]
6,423,695 Cytokine related treatments of diseaseDec 20, 99Jul 23, 02[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2010/0323,987 COMBINATIONS OF RETIGABINE AND SODIUM CHANNEL INHIBITORS OR SODIUM CHANNEL-INFLUENCING ACTIVE COMPOUNDS FOR TREATING PAINSABANAug 30, 10Dec 23, 10[A61P, A61K]
2009/0196,853 METHOD OF TREATING HEPATITIS VIRUS INFECTION WITH A MULTIPHASIC INTERFERON DELIVERY PROFILEABANApr 08, 09Aug 06, 09[A61P, A61K]
2009/0176,721 NUCLEOSIDE ANALOGS WITH CARBOXAMIDINE MODIFIED MONOCYCLIC BASEABANMar 09, 09Jul 09, 09[A61P, A61K]
2008/0108,952 DRUG DELIVERY SYSTEM FOR ADMINISTERING AN ADJUSTABLE PRESET DOSEABANJan 15, 08May 08, 08[A61M]
2008/0045,534 Derivatives of 1,3-diamino benzene as potassium channel modulatorsABANAug 16, 07Feb 21, 08[C07D, C07C, A61P, A61K]
2005/0089,559 Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating painsABANDec 05, 03Apr 28, 05[A61K]
2005/0031,586 Method for treating hepatitis c virus infection in treatment failure patientsABANAug 20, 04Feb 10, 05[A61K]
6,743,902 Sugar modified nucleosidesExpiredOct 25, 00Jun 01, 04[C07H, C12Q]
6,191,266 Sugar modified nucleosidesExpiredDec 16, 96Feb 20, 01[C07H]
5,712,378 Sugar modified nucleosides and their use for synthesis of oligonucleotidesExpiredNov 02, 95Jan 27, 98[C07H, C12Q]

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.